Peter Verwaijen
Verkoop & Marketing bij EGETIS THERAPEUTICS AB
Actieve functies van Peter Verwaijen
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| EGETIS THERAPEUTICS AB | Verkoop & Marketing | 05-05-2022 | - |
Loopbaan van Peter Verwaijen
Eerdere bekende functies van Peter Verwaijen
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
AM-Pharma BV
 AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Financieel Directeur/CFO | 17-04-2009 | - |
Glaucus Proteomics BV
 Glaucus Proteomics BV Miscellaneous Commercial ServicesCommercial Services Glaucus Proteomics BV develops antibody and protein array technologies to optimize drug development and disease management. The company was founded in 2000 and is headquartered in Utrecht, the Netherlands. | Comptroller/Controller/Auditor | - | - |
Statistieken
Internationaal
| Nederland | 3 |
| Zweden | 2 |
Operationeel
| Comptroller/Controller/Auditor | 1 |
| Director of Finance/CFO | 1 |
| Sales & Marketing | 1 |
Sectoraal
| Health Technology | 3 |
| Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| EGETIS THERAPEUTICS AB | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Glaucus Proteomics BV
Glaucus Proteomics BV Miscellaneous Commercial ServicesCommercial Services Glaucus Proteomics BV develops antibody and protein array technologies to optimize drug development and disease management. The company was founded in 2000 and is headquartered in Utrecht, the Netherlands. | Commercial Services |
AM-Pharma BV
AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Health Technology |
- Beurs
- Insiders
- Peter Verwaijen
- Ervaring
